|Legal Status||Class B|
Penalty for possession: Up to five years in prison and / or an unlimited fine.
Penalty for dealing: Up to 14 years in prison and / or an unlimited fine.
Cannabis grows in many parts of the world, but the main centres of commercial production include north and west Africa, south America, middle and far East. Increasingly being grown indoors in Europe. The main Psychoactive ingredient of cannabis is Tetrahydrocannabinol (THC). The earliest recorded medical use of cannabis was in China, 4,000 years ago, and many cultures have valued its medicinal properties since. Nowadays, synthetic forms, known as marinol and nabilone, are sometimes used as an Anti-Emetic to control nausea and vomiting in cancer patients. Proponents believe that cannabis could be used to beneficial effect in a range of illnesses from glauComa to multiple sclerosis (MS). Medical cannabis is prescribed for nausea, pain and alleviation of symptoms surrounding chronic illness, but its use remains controversial. Low level THC and other cannabinoids have been shown to have Analgesic, anti-spasmodic, anti-convulsant, anti-tremor, anti-psychotic, anti-inflammatory, anti-emetic and appetite-Stimulant properties. Research is ongoing into the medical effects of cannabinoids.
|Short Term Effects||
Relaxation, euphoria, hilarity, anxiety, Paranoia, confusion, low blood pressure, short term memory loss, increased appetite (munchies). Other short-term effects may include confusion, memory loss, Paranoia, laziness. Resin, like other drugs, can be 'Cut' with other substances to bulk it out. The effects and health risks associated with this are difficult to determine depending what goes in to the resin mix. Substances like boot polish, animal dung and other drugs have been known to be added to cannabis resin.
|Long Term Effects||
Habituation, Paranoia, damage to lung tissue, risk of developing mental health problems.
Identified in Sweden: 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one (norfludiazepam). Norfludiazepam is a benzodiazepine and is structurally related to the internationally controlled substance diazepam.
WEDINOS Service upgrade…: Great news following Welsh Governments recent funding of the project until 2025, all our new analytical tools are in place. Our analysts have completed their training and familiarisation and will, over the next fortnight, be working through the backlog of samples generated as a result of this necessary pause in service. Normal testing and service turnaround times should resume at the beginning of June. We thank you for your continued support and patience.